Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#2945 Misdiagnosis of Pancreatic Neuroendocrine Carcinoma - A Potential Threat
Introduction: Pancreatic neuroendocrine tumors (PNETs) are a rare clinical entity.Very less data is available in Pakistan on PNETs.Common metastatic sites are liver, lung and brain Reports involving metastasis to breast are almost negligible.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Athar A,
Keywords: Breast Carcinoma, PNETs, Misdiagnosis,
Introduction: WHO classification from 2003 defines primary neuroendocrine carcinomas (NEC) of the breast as a group of tumors with expression of neuroendocrine markers in more than 50% of tumor cells. In the current WHO classification this category is renamed to “carcinomas with neuroendocrine features” without defined clear-cut of the percentage of tumor cells positive for neuroendocrine markers.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Demirovic A
Authors: Demirović A, Vranic S, Skenderi F, Peric Balja M, Ulamec M,
Keywords: breast cancer, special types, carcinoma with neuroendocrine features, neuroendocrine markers,
#716 Adrenal Metastases and Neuroendocrine Breast Carcinoma in a MEN-1 Patient
Introduction: In Multiple Endocrine Neoplasia type 1 (MEN-1) pituitary, parathyroid and pancreatic/duodenal endocrine cells are typically involved. Other neoplasms also occur.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Pasquali C
Authors: Moletta L, Milanetto A, Sperti C, Alaggio R, Pedrazzoli S,
Keywords: MEN-1 syndrome, breast cancer, adrenal metastasis, rare tumors,
Introduction: Primary neuroendocrine carcinoma of the breast is an extremely rare tumor with incidence of 0.27-0.5%.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author:
Authors: Macut D, Kecman G, Bogavac T, Popovic B, Bozic I,
Keywords: neuroendocrine carcinoma, breast carcinoma, hormonal therapy,